Optimizing dermatological formulations of retinoic acid.
D000818:Animals; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D004487:Edema / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D005233:Fatty Alcohols; D007509:Irritants / Q000008:administration & dosage; D007928:Lethal Dose 50; D008297:Male; D009824:Ointments / Q000032:analysis; D014677:Pharmaceutical Vehicles; D011817:Rabbits; D012867:Skin / Q000187:drug effects; D012995:Solubility; D014801:Vitamin A / Q000008:administration & dosage* / Q000032:analysis / Q000302:isolation & purification / Q000494:pharmacology
D003879:Dermatologic Agents; D005233:Fatty Alcohols; D007509:Irritants; D009824:Ointments; D014677:Pharmaceutical Vehicles; D014801:Vitamin A